Viewing Study NCT00006269

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:50 PM
Ignite Modification Date: 2026-02-22 @ 6:44 PM
Study NCT ID: NCT00006269
Status: TERMINATED
Last Update Posted: 2012-05-25
First Post: 2000-09-11
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Octreotide in the Prevention of Diarrhea in Patients Receiving Irinotecan for Metastatic Colon Cancer
Sponsor: Novartis
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Colorectal Cancer View
None Diarrhea View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage IV colon cancer View
None stage IV rectal cancer View
None recurrent colon cancer View
None recurrent rectal cancer View
None diarrhea View